Venus Remedies rises on bagging Australian GMP from TGA for four of its facilities

15 Feb 2013 Evaluate

Venus Remedies is currently trading at Rs. 269.90, up by 1.30 points or 0.48% from its previous closing of Rs. 268.60 on the BSE.

The scrip opened at Rs. 270.85 and has touched a high and low of Rs. 274.30 and Rs. 265.05 respectively. So far 3116 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 327.80 on 05-Dec-2012 and a 52 week low of Rs. 155.00 on 27-Mar-2012.

Last one week high and low of the scrip stood at Rs. 285.00 and Rs. 251.45 respectively. The current market cap of the company is Rs. 262.10 crore.

The promoters holding in the company stood at 34.22% while Institutions and Non-Institutions held 14.45% and 51.33% respectively.

Venus Remedies has added another milestone in the form of Good Manufacturing Practices (GMF) as the company has got approval from Therapeutic Goods Administration (TGA) Australia for four of its facilities - Cephalosporin, Carapenems and Oncology liquid and Oncology lyophilized.

With the grant of TGA approval, the company has once again proved that its manufacturing facilities are in-line with international regulatory standards. This development would now enable the company to export these products into Australian market. Venus has already filed dossier for meropenem which is on the verge of registration and TGA approval of facility will further expedite the process.

Besides, the company is planning to enter this market through strategic tie ups with local players, where huge market potential is forecasted for Docetaxel single vial, Gemcitabine, Topotecan, Innotecan, Imipenem cilastatin. For these four manufacturing facilities company possesses 18 international GMP certifications from different international regulatory agencies like EUGMP, INVIMA, UKRAINE, SFDA and GCC.

Venus Remedies is a pharmaceutical manufacturing company. The company provides formulations in area of antibiotics and oncological therapeutics. The company has two manufacturing facilities located in India and Germany. It manufactures Oncological and Cefelosporine Injectable products.

Venus Remedies Share Price

774.95 29.75 (3.99%)
08-Dec-2025 15:32 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 920.90
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×